CTOs on the Move

Vector New England

www.vectornewengland.com

 
Enhance every aspect of your business with our IBM collaboration software. We offer a multitude of Enterprise Business Solutions to improve your company.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Good Fruit Grower

Good Fruit Grower is a Yakima, WA-based company in the Software and Internet sector.

Orion International

Orion International is a Raleigh, NC-based company in the Software and Internet sector.

Resolve Systems

Resolve helps enterprise IT teams achieve agileoperations with an industry-leading intelligent automation platform that powers more than a million automations every day – from simple, repetitive tasks to insanely complex processes that go well beyond what you imagine is automatable. Purpose-built to address challenges posed by increasing IT complexity, Resolve`s no-code IT automation enables organizations to maximize operational efficiency, reduce costs, quickly troubleshoot and fix problems, improve service levels, accelerate service delivery, and deliver rapid time to value.

Interactions

Interactions LLC is a privately held technology company that builds and delivers hosted Virtual Assistant applications that enable businesses to deliver automated natural language communications for enterprise customer care.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.